Researchers at Rice University announced a novel use for batroxobin , a hemotoxic component in the venom of two South American pit viper species. They’ve figured out how to leverage it as a potent anticoagulant — when combined with a nanofiber hydrogel called SB50 — that could save countless lives in surgery. Medical science has actually been employing batroxobin as a topical clotting agent and thrombosis treatment since the mid 1930s. But more importantly, it’s been shown to stop the flow of blood even if the patient is on heparin, a powerful anticoagulant administered before some surgeries. Via: Rice University Newsroom Source: Rice University

Read More:
Nanofiber gel and snake venom work together to stop the bleeding